This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Did you know that the infusion pharmacy market is projected to reach $20 billion dollars by 2027? Infusion pharmacy, also known as home care or specialty pharmacy, encompasses a variety of crucial medical services. This remarkable feedback underscores the positive impact these professionals have on patientcare and overall wellbeing.
It's estimated the worldwide healthcare cloud computing market will increase at an annual growth rate of 17 percent by 2027. Save user time through a single sign-on that increases efficiency and eliminates multiple data entry points, allowing you to focus on patientcare rather than OmniCenter server administration.
It's estimated the worldwide healthcare cloud computing market will increase at an annual growth rate of 17 percent by 2027. Save user time through a single sign-on that increases efficiency and eliminates multiple data entry points, allowing you to focus on patientcare rather than OmniCenter server administration.
Specifically, FDA determined that Avadel’s Lumryz can “break” Jazz’s ODE because it is “clinically superior” based on Lumryz’s “major contribution to patientcare,” rendering it not “the same drug” under the Orphan Drug Act.
Their overall goal is to reduce freshwater withdrawal by 90% by 2027 (the equivalent of 600 million liters of freshwater). Takeda is the first pharmaceutical company worldwide to have implemented this water preservation project, in collaboration with a Belgian start-up Ekopak, on a large scale.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content